Publication | Closed Access
Changes in Anti-HuD Antibody Titers in the Long-Term Course in Paraneoplastic Sensory Neuropathy
14
Citations
0
References
1997
Year
Anti-hud Antibody TitersSystemic DiseasesNeurological DisorderCorticobasal DegenerationClinical NeurologyNeuropathic PainPeripheral NerveDermatologyCommon Neurological DisordersPeripheral NervesNeuromasKinki UniversityFebruary 14Peripheral Nervous SystemLong-term CourseNeurobiology Of DiseaseExperimental NeuropathologyNeurologyParaneoplastic Sensory NeuropathyNeuropathologyNeuroimmunologySensationAllergyOphthalmologyNeuroepidemiologyCommon DiseasesSclerodermaNeuromuscular PathologyMovement DisordersClinical DisordersNeuroanatomyDegenerative DiseaseCentral Nervous SystemMedicine
Case Reports| February 14 2008 Changes in Anti-HuD Antibody Titers in the Long-Term Course in Paraneoplastic Sensory Neuropathy Subject Area: Neurology and Neuroscience Yuji Yagi; Yuji Yagi aDepartment of Neurology, School of Medicine, Kinki University, Osakasayama, Japan; Search for other works by this author on: This Site PubMed Google Scholar Takashi Inuzuka; Takashi Inuzuka bDepartment of Neurology, Brain Research Institute, Niigata University, Niigata, Japan Search for other works by this author on: This Site PubMed Google Scholar Kazuo Takada; Kazuo Takada aDepartment of Neurology, School of Medicine, Kinki University, Osakasayama, Japan; Search for other works by this author on: This Site PubMed Google Scholar Ryoichi Nakano; Ryoichi Nakano bDepartment of Neurology, Brain Research Institute, Niigata University, Niigata, Japan Search for other works by this author on: This Site PubMed Google Scholar Isao Hozumi; Isao Hozumi bDepartment of Neurology, Brain Research Institute, Niigata University, Niigata, Japan Search for other works by this author on: This Site PubMed Google Scholar Haruko Yoshimoto; Haruko Yoshimoto bDepartment of Neurology, Brain Research Institute, Niigata University, Niigata, Japan Search for other works by this author on: This Site PubMed Google Scholar Osam Onodera; Osam Onodera bDepartment of Neurology, Brain Research Institute, Niigata University, Niigata, Japan Search for other works by this author on: This Site PubMed Google Scholar Keiko Tanaka; Keiko Tanaka bDepartment of Neurology, Brain Research Institute, Niigata University, Niigata, Japan Search for other works by this author on: This Site PubMed Google Scholar Shuzo Sato; Shuzo Sato bDepartment of Neurology, Brain Research Institute, Niigata University, Niigata, Japan Search for other works by this author on: This Site PubMed Google Scholar Mitsuo Takahashi Mitsuo Takahashi aDepartment of Neurology, School of Medicine, Kinki University, Osakasayama, Japan; Search for other works by this author on: This Site PubMed Google Scholar Eur Neurol (1997) 37 (2): 122–123. https://doi.org/10.1159/000117422 Article history Published Online: February 14 2008 Content Tools Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Tools Icon Tools Get Permissions Cite Icon Cite Search Site Citation Yuji Yagi, Takashi Inuzuka, Kazuo Takada, Ryoichi Nakano, Isao Hozumi, Haruko Yoshimoto, Osam Onodera, Keiko Tanaka, Shuzo Sato, Mitsuo Takahashi; Changes in Anti-HuD Antibody Titers in the Long-Term Course in Paraneoplastic Sensory Neuropathy. Eur Neurol 1 February 1997; 37 (2): 122–123. https://doi.org/10.1159/000117422 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsEuropean Neurology Search Advanced Search Article PDF first page preview Close Modal This content is only available via PDF. 1997Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. You do not currently have access to this content.